Mao Zhang,Yingying Huang,Jiaomeng Pan,Chen Sang,Youpei Lin,Liangqing Dong,Xia Shen,Yingcheng Wu,Guohe Song,Shuyi Ji,Fen Liu,Mengcheng Wang,Yuyan Zheng,Sirui Zhang,Zefeng Wang,Jianke Ren,Daming Gao,Jian Zhou,Jia Fan,Wu Wei,Jian Lin,Qiang Gao

Abstract:KRAS mutations are causally linked to pro-tumor inflammation and identified as driving factors in tumorigenesis. Here, using multi-omics data gathered from a large set of patients, we showed that KRAS mutation was associated with a specific landscape of alternative mRNA splicing that connected to myeloid inflammation in intrahepatic cholangiocarcinoma (iCCA). Then, we identified a negative feedback mechanism in which the upregulation of interleukin 1 receptor antagonist (IL1RN)-201/203 due to alternative splicing confers vital anti-inflammatory effects in KRAS mutant iCCA. In KRAS mutant iCCA mice, both IL1RN-201/203 upregulation and anakinra treatment ignited a significant anti-tumor immune response by altering neutrophil recruitment and phenotypes. Furthermore, anakinra treatment synergistically enhanced anti-PD-1 therapy to activate intratumoral GZMB+ CD8+ T cells in KRAS mutant iCCA mice. Clinically, we found that high IL1RN-201/203 levels in KRAS mutant iCCA patients were significantly associated with superior response to anti-PD-1 immunotherapy.

Supplementary Table S1 from an Inflammatory Checkpoint Generated by <i>il1rn</i> Splicing Offers Therapeutic Opportunity for &Lt;i>kras</i>-Mutant Intrahepatic Cholangiocarcinoma

Supplementary Table S2 from an Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma

Supplementary Table S5 from an Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma

Supplementary Figures S1-9 from An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i>-Mutant Intrahepatic Cholangiocarcinoma

An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma

Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Table S1 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Table S2 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Table S3 from Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma

Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Table S4 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table S2 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Supplementary Table S3 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Supplementary Materials, Methods and Tables from Downregulation of <i>safb</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>tak1</i> During the Progression of Colorectal Cancer

Supplementary Table 6 from <i>linc00869</i> Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Figure S1 from Immune Checkpoint Inhibition is Safe and Effective for Liver Cancer Prevention in a Mouse Model of Hepatocellular Carcinoma

Supplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence

Supplementary Table S1 from an Inflammatory Checkpoint Generated by &lt;i&gt;il1rn&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &Lt;i&gt;kras&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma